OrphanDrug
OrphanDrug
Pharma Knowledge Base

transthyretin amyloidosis

ORPHA: 85447

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

HEREDITARY AMYLOIDOSIS

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with transthyretin amyloidosis, sourced from HPO and Orphanet clinical annotations.

NephropathyPolyneuropathyImpotenceCardiomyopathyCardiomegalyAtrioventricular blockWeight lossDiarrheaConstipationArrhythmiaConstrictive median neuropathyAbnormal renal physiologyAbnormal autonomic nervous system physiologyVitreous floaters

Classification & Codes

Orphanet Code

ORPHA:85447
transthyretin amyloidosis
OrphanetORPHA:85447
Treatments0 drug(s)
Symptoms on record14 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO